Kaibori M - Search Results

1

Effects of implementing an "enhanced recovery after surgery" program on patients undergoing resection of hepatocellular carcinoma.

Kaibori M, Matsui K, Ishizaki M, Iida H, Yoshii K, Asano H, Kon M. Kaibori M, et al. Surg Today. 2017 Jan;47(1):42-51. doi: 10.1007/s00595-016-1344-2. Epub 2016 May 10. Surg Today. 2017. PMID: 27165267

2

Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study.

Matsui Y, Uhara J, Satoi S, Kaibori M, Yamada H, Kitade H, Imamura A, Takai S, Kawaguchi Y, Kwon AH, Kamiyama Y. Matsui Y, et al. Among authors: kaibori m. J Hepatol. 2002 Jul;37(1):78-86. doi: 10.1016/s0168-8278(02)00091-0. J Hepatol. 2002. PMID: 12076865 Clinical Trial.

3

Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.

Kaibori M, Matsui Y, Kitade H, Kwon AH, Kamiyama Y. Kaibori M, et al. Hepatogastroenterology. 2003 Mar-Apr;50(50):491-6. Hepatogastroenterology. 2003. PMID: 12749254

4

Refractoriness to platelet transfusion following partial hepatectomy for hepatocellular carcinoma: report of two cases.

Kaibori M, Nagahama T, Yokoigawa N, Yanagida H, Nakamoto H, Kitade H, Satoi S, Onishi S, Kwon AH, Kamiyama Y. Kaibori M, et al. Hepatogastroenterology. 2003 May-Jun;50(51):832-6. Hepatogastroenterology. 2003. PMID: 12828097

5

Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.

Kaibori M, Matsui Y, Yanagida H, Yokoigawa N, Kwon AH, Kamiyama Y. Kaibori M, et al. World J Surg. 2004 Jul;28(7):702-7. doi: 10.1007/s00268-004-7205-y. Epub 2004 Jun 8. World J Surg. 2004. PMID: 15185000

6

Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma.

Kaibori M, Tanigawa N, Matsui Y, Kwon AH, Sawada S, Kamiyama Y. Kaibori M, et al. Anticancer Res. 2004 May-Jun;24(3b):1929-33. Anticancer Res. 2004. PMID: 15274379 Free article. Clinical Trial.

7

Prognosis of hepatocellular carcinoma after hepatectomy in patients with renal dysfunction.

Kaibori M, Matsui Y, Kwon AH, Tokoro T, Kamiyama Y. Kaibori M, et al. World J Surg. 2005 Mar;29(3):375-81. doi: 10.1007/s00268-004-7515-0. World J Surg. 2005. PMID: 15891937

8

Hepatocyte growth factor stimulates the induction of cytokine-induced neutrophil chemoattractant through the activation of NF-kappaB in rat hepatocytes.

Kaibori M, Yanagida H, Nakanishi H, Ozaki T, Yoshida H, Matsui K, Hijikawa T, Kamiyama Y, Okumura T. Kaibori M, et al. J Surg Res. 2006 Jan;130(1):88-93. doi: 10.1016/j.jss.2005.09.025. Epub 2005 Nov 3. J Surg Res. 2006. PMID: 16271365

9

Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C.

Kaibori M, Matsui Y, Hijikawa T, Uchida Y, Kwon AH, Kamiyama Y. Kaibori M, et al. Surgery. 2006 Mar;139(3):385-94. doi: 10.1016/j.surg.2005.08.035. Surgery. 2006. PMID: 16546504

10

Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection.

Kwon AH, Matsui Y, Kaibori M, Ha-Kawa SK. Kwon AH, et al. Among authors: kaibori m. Surgery. 2006 Sep;140(3):379-86. doi: 10.1016/j.surg.2006.02.011. Surgery. 2006. PMID: 16934599 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters